Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - The Managing Agitation and Raising QUality of LifE in Dementia (MARQUE) study

PloS One
M PancaR M Hunter

Abstract

People with dementia living in care homes often experience clinically significant agitation; however, little is known about its economic impact. To calculate the cost of agitation in people with dementia living in care homes. We used the baseline data from 1,424 residents with dementia living in care homes (part of Managing Agitation and Raising QUality of lifE in dementia (MARQUE) study) that had Cohen-Mansfield Agitation Inventory (CMAI) scores recorded. We investigated the relationship between residents' health and social care costs and severity of agitation based on the CMAI total score. In addition, we assessed resource utilisation and compared costs of residents with and without clinically significant symptoms of agitation using the CMAI over and above the cost of the care home. Agitation defined by the CMAI was a significant predictor of costs. On average, a one-point increase in the CMAI will lead to a 0.5 percentage points (cost ratio 1.005, 95%CI 1.001 to 1.010) increase in the annual costs. The excess annual cost associated with agitation per resident with dementia was £1,125.35. This suggests that, on average, agitation accounts for 44% of the annual health and social care costs of dementia in people living in care ...Continue Reading

References

May 1, 1989·Journal of Gerontology·J Cohen-MansfieldA S Rosenthal
Oct 1, 1986·Journal of the American Geriatrics Society·J Cohen-Mansfield, N Billig
Sep 24, 2002·JAMA : the Journal of the American Medical Association·Constantine G LyketsosSteven DeKosky
Mar 21, 2003·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·David E VanceAnn Yurick
Mar 18, 2004·Clinics in Geriatric Medicine·Sanford I Finkel
Oct 29, 2004·Journal of Health Services Research & Policy·Julie Barber, Simon Thompson
Jul 5, 2005·Journal of Palliative Medicine·Joseph W ShegaGreg A Sachs
Mar 12, 2011·Journal of the American Geriatrics Society·Toru OkuraKenneth M Langa
May 18, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Anders GustavssonLinus Jönsson
May 16, 2012·Frontiers in Neurology·J CerejeiraE B Mukaetova-Ladinska
Mar 19, 2014·Journal of the American Geriatrics Society·Helen C KalesUNKNOWN Detroit Expert Panel on Assessment and Management of Neuropsychiatric Symptoms of Dementia
Jul 30, 2014·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Ansgar WübkerDirk Sauerland
Dec 26, 2017·Journal of the American Medical Directors Association·Nadège CostaUNKNOWN RightTimePlaceCare consortium

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.